2024 EVENT SITE

WMIF MAIN SITE

Johannes Fruehauf, MD, PhD

With his background as a physician working in diverse health systems, coupled with 20+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to supporting life science entrepreneurs and start-up companies. Dr. Fruehauf is currently General Partner and co-founder of Mission BioCapital (MBC). In his role at MBC, Johannes sources, diligences, and leads new life-science investment transactions and represents the fund on the board of a number of MBC portfolio companies.

He is also the Founder and President of LabCentral and BioLabs, the largest provider of laboratory co-working space for startups nationwide, currently serving over 385+ startups in 15 cities.  Over the past three years, the companies started within this network secured over 25% of all Seed and Series A venture capital invested in life sciences in the US.  LabCentral and BioLabs were also the recipient of the prestigious Prix Galien Award in 2022 for the best biotech startup launchpads in the “Incubators, Accelerators and Equity” category.

Johannes studied medicine in Germany and France, while also conducting field work in Africa (Zimbabwe and Guinea). Thereafter, he practiced medicine (internal medicine and OB/Gyn) for several years in Germany before coming to Boston for a post-doc at Beth Israel Deaconess Medical Center/Harvard Medical School.  Johannes graduated from University of Frankfurt and received his doctorate from the University of Heidelberg. He is also the author of over 30 peer reviewed publications and is named inventor on 9 issued patents on drug delivery and RNAi-based therapeutics.

Founder & General Partner, Mission BioCapital;

Co-Founder & President, LabCentral;

CEO, BioLabs

Subscribe

Join our email list to receive exclusive offers

Opt In